Tamar Harel Adar, PhD – VP R&D

An expert in biotechnology with experience at CollPlant (NASDAQ: CLGN) and Cellect (NASDAQ: APOP). She holds a Ph.D. in Biotechnology Engineering from Ben-Gurion University.

 

Member of the ‘Best Practice Task Force’ focused on the standardization of iPSC-based therapy, led by ISSCR (International Society for Stem Cell Medicine)